Zhang et al. [24] have reported that CircPLEKHM3 exerts tumor-suppressive effects in OC cells by targeting the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis and can be used as a prognostic indicator and therapeutic target for OC. Here, BRCA1 is linked to neoplasm.